Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-30 9:28 pm Sale |
2025-07-25 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 773,754 6.920% |
-7,235,159 (-90.34%) |
Filing History |
| 2025-07-29 4:53 pm Purchase |
2025-07-25 | 13D | Ikena Oncology, Inc. IKNA |
Atlas Venture Fund X, L.P. | 241,800 2.100% |
241,800 (New Position) |
Filing History |
| 2025-07-28 2:16 pm Purchase |
2025-07-25 | 13D | Ikena Oncology, Inc. IKNA |
BML Investment Partners, L.P. | 220,832 1.900% |
220,832 (New Position) |
Filing History |
| 2025-06-18 8:23 pm Purchase |
2025-06-14 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 8,008,913 16.710% |
5,819,802 (+265.85%) |
Filing History |
| 2025-06-16 12:21 pm Purchase |
2025-06-16 | 13D | Ikena Oncology, Inc. IKNA |
BML Investment Partners, L.P. | 4,090,102 8.500% |
444,236 (+12.18%) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2025-02-07 | 13G | Ikena Oncology, Inc. IKNA |
Deep Track Capital, LP | 2,515,513 5.210% |
2,515,513 (New Position) |
Filing History |
| 2025-02-14 4:22 pm Sale |
2024-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 4,006,564 8.300% |
-762,600 (-15.99%) |
Filing History |
| 2025-02-14 10:47 am Unchanged |
2024-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BML Investment Partners, L.P. | 3,645,866 7.600% |
0 (Unchanged) |
Filing History |
| 2025-02-13 4:22 pm Sale |
2024-12-31 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC. GILD |
1,521,312 3.600% |
-1,410,155 (-48.10%) |
Filing History |
| 2024-12-31 3:44 pm Purchase |
2024-12-23 | 13G | Ikena Oncology, Inc. IKNA |
BML Investment Partners, L.P. | 3,645,866 7.600% |
3,645,866 (New Position) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 4,091,118 8.480% |
4,091,118 (New Position) |
Filing History |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 4.400% |
0 (Unchanged) |
Filing History |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 1,215,002 2.771% |
-2,969,291 (-70.96%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 178,177 0.400% |
-1,976,957 (-91.73%) |
Filing History |
| 2024-02-14 4:48 pm Unchanged |
2023-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Omega Fund VI, L.P. | 2,249,123 4.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:47 am Purchase |
2023-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 4,769,164 9.900% |
2,266,093 (+90.53%) |
Filing History |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 4,184,293 9.545% |
459,718 (+12.34%) |
Filing History |
| 2023-10-19 3:33 pm Purchase |
2023-10-11 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC. GILD |
2,931,467 6.700% |
2,931,467 (New Position) |
Filing History |
| 2023-09-21 4:52 pm Sale |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,189,111 5.200% |
-153,121 (-6.54%) |
Filing History |
| 2023-09-14 4:21 pm Purchase |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,342,232 5.500% |
405,346 (+20.93%) |
Filing History |